194 related articles for article (PubMed ID: 35713230)
1. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
[No Abstract] [Full Text] [Related]
2. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
[TBL] [Abstract][Full Text] [Related]
3. Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.
Lin Q; Zhang M; Tang H; Shen Y; Zhu Y; Xu Q; Li X
Rheumatol Int; 2020 May; 40(5):811-819. PubMed ID: 31377830
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome as initial presentation of systemic lupus erythematosus.
Yeap ST; Sheen JM; Kuo HC; Hwang KP; Yang KD; Yu HR
Pediatr Neonatol; 2008 Apr; 49(2):39-42. PubMed ID: 18947015
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
7. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
8. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review.
Vilaiyuk S; Sirachainan N; Wanitkun S; Pirojsakul K; Vaewpanich J
Clin Rheumatol; 2013 Jun; 32(6):899-904. PubMed ID: 23483294
[TBL] [Abstract][Full Text] [Related]
9. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
Tulbă D; Balea M; Băicuş C
Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
[TBL] [Abstract][Full Text] [Related]
12. The incidence of macrophage activation syndrome in children with rheumatic disorders.
Moradinejad MH; Ziaee V
Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report.
Fioravante da Silveira L; Zago A; Zanchet D; Chemello D
Reumatismo; 2023 Jul; 75(2):. PubMed ID: 37462126
[TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
[TBL] [Abstract][Full Text] [Related]
15. Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage.
Sukhadiya P; Kumar P; Meena DS; Kumar P H A; Vijayan N; Garg P; Garg MK
Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942984
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE).
Szulawski R; Kourlas PJ; Antonchak M
Am J Case Rep; 2018 Jun; 19():734-738. PubMed ID: 29930239
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus complicated with macrophage activation syndrome mimicking COVID-19 multisystemic inflammatory syndrome in children.
Domínguez-Rojas J; Atamari-Anahui N; Chonlon-Murillo K; Tello M; Coronado-Muñoz Á
Bol Med Hosp Infant Mex; 2021; 78(6):642-646. PubMed ID: 34934208
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
Aoyama-Maeda N; Horino T; Ichii O; Terada Y
Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
